Literature DB >> 23918763

Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis.

Karen W Gripp1, Dina J Zand, Laurie Demmer, Carol E Anderson, William B Dobyns, Elaine H Zackai, Elizabeth Denenberg, Kim Jenny, Deborah L Stabley, Katia Sol-Church.   

Abstract

Noonan syndrome is a heterogenous rasopathy typically presenting with short stature, characteristic facial features, cardiac abnormalities including pulmonic valve stenosis, ASD and hypertrophic cardiomyopathy (HCM), cryptorchidism, ectodermal abnormalities, and learning differences. The phenotype is variable, and limited genotype phenotype correlation exists with SOS1 mutations often associated with normal cognition and stature, RAF1 mutations entailing a high HCM risk, and certain PTPN11 mutations predisposing to juvenile myelomonocytic leukemia. The recently identified SHOC2 mutation (p.Ser2Gly) causes Noonan syndrome with loose anagen hair. We report five patients with this mutation. All had skin hyperpigmentation, sparse light colored hair, increased fine wrinkles, ligamentous laxity, developmental delay, and 4/4 had a structural cardiac anomaly. Hypotonia and macrocephaly occurred in 4/5 (80%); 3/5 (60%) had polyhydramnios, increased birth weight or required use of a feeding tube. Distinctive brain abnormalities included relative megalencephaly and enlarged subarachnoid spaces suggestive of benign external hydrocephalus, and a relatively small posterior fossa as indicated by a vertical tentorium. The combination of a large brain with a small posterior fossa likely resulted in the high rate of cerebellar tonsillar ectopia (3/4; 75%). Periventricular nodular heterotopia was seen in one patient with a thick and dysplastic corpus callosum. We report on the first hematologic neoplasm, myelofibrosis, in a 2-year-old patient with SHOC2 mutation. Myelofibrosis is exceedingly rare in children and young adults. The absence of a somatic JAK2 mutation, seen in the majority of patients with myelofibrosis, is noteworthy as it suggests that germline or somatic SHOC2 mutations are causally involved in myelofibrosis.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Chiari 1 malformation; Noonan syndrome with loose anagen hair; SHOC2; heterotopia; malignancy; myelofibrosis; rasopathy

Mesh:

Substances:

Year:  2013        PMID: 23918763      PMCID: PMC3787995          DOI: 10.1002/ajmg.a.36098

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  35 in total

Review 1.  Janus kinases: components of multiple signaling pathways.

Authors:  S G Rane; E P Reddy
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

2.  Type 1 Arnold-Chiari malformation and Noonan syndrome. A new diagnostic feature?

Authors:  Muriel Holder-Espinasse; Robin M Winter
Journal:  Clin Dysmorphol       Date:  2003-10       Impact factor: 0.816

3.  Noonan-like syndrome with loose anagen hair: a new syndrome?

Authors:  Laura Mazzanti; Emanuele Cacciari; Alessandro Cicognani; Rosalba Bergamaschi; Emanuela Scarano; Antonino Forabosco
Journal:  Am J Med Genet A       Date:  2003-04-30       Impact factor: 2.802

4.  Chiari (type 1) malformation and syringomyelia in a patient with Noonan's syndrome.

Authors:  A Peiris; M J Ball
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-08       Impact factor: 10.154

5.  Association between Noonan syndrome and Chiari I malformation: a case-based update.

Authors:  Yann Shern Keh; Laurence Abernethy; Benedetta Pettorini
Journal:  Childs Nerv Syst       Date:  2012-12-14       Impact factor: 1.475

6.  Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

Authors:  R A Mesa; M N Silverstein; S J Jacobsen; P C Wollan; A Tefferi
Journal:  Am J Hematol       Date:  1999-05       Impact factor: 10.047

7.  Activating CBL mutations are associated with a distinct MDS/MPN phenotype.

Authors:  Juliana Schwaab; Thomas Ernst; Philipp Erben; Jenny Rinke; Susanne Schnittger; Philipp Ströbel; Georgia Metzgeroth; Max Mossner; Torsten Haferlach; Nicholas C P Cross; Andreas Hochhaus; Wolf-Karsten Hofmann; Andreas Reiter
Journal:  Ann Hematol       Date:  2012-08-10       Impact factor: 3.673

8.  Noonan syndrome due to a SHOC2 mutation presenting with fetal distress and fatal hypertrophic cardiomyopathy in a premature infant.

Authors:  Rebecca Hoban; Amy E Roberts; Laurie Demmer; Reena Jethva; Barbara Shephard
Journal:  Am J Med Genet A       Date:  2012-04-23       Impact factor: 2.802

9.  Clinical Heterogeneity in two patients with Noonan-like Syndrome associated with the same SHOC2 mutation.

Authors:  Donatella Capalbo; Maria Giuseppa Scala; Daniela Melis; Giorgia Minopoli; Nicola Improda; Loredana Palamaro; Claudio Pignata; Mariacarolina Salerno
Journal:  Ital J Pediatr       Date:  2012-09-20       Impact factor: 2.638

Review 10.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321

View more
  21 in total

Review 1.  The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.

Authors:  HyeIn Jang; Payton Stevens; Tianyan Gao; Emilia Galperin
Journal:  FEBS J       Date:  2020-07-06       Impact factor: 5.542

2.  Characteristic MR Imaging Findings of the Neonatal Brain in RASopathies.

Authors:  M N Cizmeci; M Lequin; K D Lichtenbelt; D Chitayat; P Kannu; A G James; F Groenendaal; E Chakkarapani; S Blaser; L S de Vries
Journal:  AJNR Am J Neuroradiol       Date:  2018-04-05       Impact factor: 3.825

3.  Spatial control of Shoc2-scaffold-mediated ERK1/2 signaling requires remodeling activity of the ATPase PSMC5.

Authors:  Eun Ryoung Jang; HyeIn Jang; Ping Shi; Gabriel Popa; Myoungkun Jeoung; Emilia Galperin
Journal:  J Cell Sci       Date:  2015-10-30       Impact factor: 5.285

4.  HUWE1 is a molecular link controlling RAF-1 activity supported by the Shoc2 scaffold.

Authors:  Eun Ryoung Jang; Ping Shi; Jamal Bryant; Jing Chen; Vikas Dukhande; Matthew S Gentry; HyeIn Jang; Myoungkun Jeoung; Emilia Galperin
Journal:  Mol Cell Biol       Date:  2014-07-14       Impact factor: 4.272

Review 5.  Swimming toward solutions: Using fish and frogs as models for understanding RASopathies.

Authors:  Victoria L Patterson; Rebecca D Burdine
Journal:  Birth Defects Res       Date:  2020-06-07       Impact factor: 2.344

6.  A Novel SHOC2 Variant in Rasopathy.

Authors:  Vickie Hannig; Myoungkun Jeoung; Eun Ryoung Jang; John A Phillips; Emilia Galperin
Journal:  Hum Mutat       Date:  2014-09-11       Impact factor: 4.878

7.  Hematopoietic and neural crest defects in zebrafish shoc2 mutants: a novel vertebrate model for Noonan-like syndrome.

Authors:  HyeIn Jang; Erin Oakley; Marie Forbes-Osborne; Melissa V Kesler; Rebecca Norcross; Ann C Morris; Emilia Galperin
Journal:  Hum Mol Genet       Date:  2019-02-01       Impact factor: 6.150

8.  Cardiomyopathies in Noonan syndrome and the other RASopathies.

Authors:  Bruce D Gelb; Amy E Roberts; Marco Tartaglia
Journal:  Prog Pediatr Cardiol       Date:  2015-07-01

9.  De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease.

Authors:  Lijiang Ma; Yavuz Bayram; Heather M McLaughlin; Megan T Cho; Alyson Krokosky; Clesson E Turner; Kristin Lindstrom; Caleb P Bupp; Katey Mayberry; Weiyi Mu; Joann Bodurtha; Veronique Weinstein; Neda Zadeh; Wendy Alcaraz; Zöe Powis; Yunru Shao; Daryl A Scott; Andrea M Lewis; Janson J White; Shalani N Jhangiani; Elif Yilmaz Gulec; Seema R Lalani; James R Lupski; Kyle Retterer; Rhonda E Schnur; Ingrid M Wentzensen; Sherri Bale; Wendy K Chung
Journal:  Hum Genet       Date:  2016-09-28       Impact factor: 4.132

10.  A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.

Authors:  Karen W Gripp; Kimberly A Aldinger; James T Bennett; Laura Baker; Jessica Tusi; Nina Powell-Hamilton; Deborah Stabley; Katia Sol-Church; Andrew E Timms; William B Dobyns
Journal:  Am J Med Genet A       Date:  2016-06-05       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.